1. Department of Pharmacy, Branch of Xinjiang Hami Second People��s Hospital, Hami 839001, China; 2.Department of Pharmacy, Branch of Xinjiang Hami Central Hospital, Hami 839001, China
Abstract��
OBJECTIVE To study appropriate working model and service platform of drug administration,in order to fill the gap in the field of individualized administration in rudimental hospitals. METHODS We investigated the clinical demand in pharmaceutical service via clinical practice and survey, and designed individualized administration, developed related pharmaceutical service, to contribute pharmaceutical service platform based on individualized drug administration.RESULTS Pharmaceutical service platform based on individualized doing in patients with renal dysfunction was established, by which pharmacist got effectively involved in the making and optimization of clinical dosing regimen, the levels of drug therapy was improved, and patients were treated safely, effectively, economically and reasonably.CONCLUSION Pharmaceutical service platform based on individualized dosing is easily adopted in basic hospital, and it is an efficient carrier by which pharmacist take part in pharmaceutical cares.
AI Li-Jiang-��A-Mu-Ti-,
YI Si-Kan-Da-����Wu-Ma-��,
JIA Dong-Mei- etc
.Practice and Experience of Developing Drug Administration in Primary Hospital[J] Chinese Pharmaceutical Journal, 2015,V50(7): 650-652
��
[1]
CHENG G, ZHANG J. Discussion on clinical pharmacy work in secondary hospital. Chin Her Med (�й�ҽҩ����),2010, 7(23):128-130. [2] LIU S J, KANG Q H, HUANG F. Practice and experience of clinical pharmacy work in basic hospital. J Pediatr Pharm(����ҩѧ��־), 2014, 20(1):59-61. [3] CHERTOW G M, LEE J, KUPERMAN G J, et al. Guided medication dosing for inpatients with renal insuffciecy. JAMA, 2001, 286(22):2839-2844. [4] DING Q M. Intervention Study on Optimizing Medication Orders of Inpatient with Advanced Renal Insufficiency . Beijing:Peking Union Medical University, 2010:64-74. [5] HARALD A, MALA N, SAHINE R, et al. Clinically important renal impairment in various groups of old persons. Scand J Prim Health Care, 2004, 22(4):152-156. [6] CHEN Y. Implementation of individualized drug administration by creatinine clearance rate monitoring. Pract Pharm Clin (ʵ��ҩ�����ٴ�),2008,11(1):24-25. [7] SHI Z C, WANG H F, WEI M H. Rational and individual administration drug use in the patients with kidney failure. Strait Pharm J(��Ͽҩѧ), 2013, 25(1):241-243. [8] COCKCROFT D W,GAULT M H. Prediction of creatinine clearance from serum creatinine. Nephron, 1976, 13(16):31-34. [9] ZHANG D, LI H F, BAI H D. Practice of anti-infective clinical pharmacist participating in clinical care of intractable cases. Pract Pharm Clin(ʵ��ҩ�����ٴ�), 2012, 15(8):503-505. [10] RU L. Clinical Pharmacists�� experience in individualized dosage regimen design and analysis of cases. Chin Eval Anal Drug Hosp(�й�ҽԺ��ҩ���������), 2013, 13(3):273-276.
2015, Vol. 50 